Current filters:

APP Pharmaceuticals

1 to 9 of 11 results

Generic launches of irinotecan, Primaxin and Merrem


Japan’s ASKA Pharmaceuticals has announced the launch of irinotecan, the active ingredient of Campto…

ActavisAntibiotics and Infectious diseasesAPP PharmaceuticalsASKA PharmaceuticalsFresenius KabiGenericsirinotecanMarkets & MarketingMerrem I.V.Oncology

The Medicines Co settles with APP over Angiomax


The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US…

AngiomaxAPP PharmaceuticalsCardio-vascularFresenius KabiGenericsLegalNorth AmericaPatentsPharmaceuticalThe Medicines Company

APP debuts generic Zemuron in USA


APP Pharmaceuticals, a US manufacturer of multi-source and branded injectable pharmaceutical products,…

Amino AcidsAPP PharmaceuticalsInjectionOrganonPhysostigmine SalicylateRocuronium Bromide InjectionZemuron

New division Fresenius Kabi reports first results


Fresenius Kabi Pharmaceuticals, the new holding company formed when German dialysis and home medical…

APP Pharmaceuticals

APP Puerto Rico heparin facility cleared by FDA


USA-based APP Pharmaceuticals, a provider of hospital-based injectable pharmaceutical products, says…

Amino AcidsAPP PharmaceuticalsAzithromycinBenadrylDiphenhydramineDoxycyclineheparinInjectionMonodoxOraceaPhysostigmine SalicylateZithromaxZithromax InjectionZmax

Germany's Fresenius to buy US injectables group APP for up to $4.6 billion


German dialysis and home medical care specialist Fresenius has entered into a definitive merger agreement…

APP Pharmaceuticals

APP's 4th-qtr net profit falls 70% after spinout


USA-based APP Pharmaceuticals says that its fourth quarter profit, which fell 70% to $8.5 million, was…

AbraxisAPP PharmaceuticalsBaxterBaxter Biopharma SolutionsBaxter Healthcare Corporation's BioPharma SolBaxter Internationalheparin

1 to 9 of 11 results

Back to top